Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 275 No 7366 p300
10 September 2005

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Keep balance over fitness to practise, warns CHRE

Health regulators should not place undue emphasis on the investigation of individual practitioners' fitness to practise, the Council for Healthcare Regulatory Excellence is to tell a Government regulatory review.

The view is set out in a paper (PDF 80K) to be adopted at a meeting of the CHRE this week after The Journal went to press. The review is being conducted by the Department of Health’s director of workforce, Andrew Foster (PJ, 19 March, p323).

The CHRE takes the view that fitness to practise measures affect few registrants, although they provide feedback that can help improve other regulatory functions, such as initial registration, ensuring the maintenance of knowledge, skills and attitudes, and setting expected standards of conduct.

It also suggests that consideration be given to bringing all health regulators together under a single Act of Parliament, rather than use a series of Section 60 Orders to modify individual regulatory Acts.

Possible advantages the CHRE sees in such a change include accelerating the pace of change, reducing duplication of effort, increased transparency and greater harmonisation. Disadvantages include the complexity of drafting any new Act and the delays it would bring to reforms in the short and medium term. The CHRE paper does not set out any discussion of the advantages or disadvantages of Section 60 Orders.

The paper also raises the question of the extent to which promoting a profession is a regulatory function.

It takes the view that where a regulator’s functions explicitly include professional promotion, this should be no more than promoting the understanding of the profession by the public. However, the paper acknowledges the existence of the alternative views that regulators should have no promotional role at all or that they should actively promote their members’ ability to fulfil health care needs.

Back to Top


©The Pharmaceutical Journal